Bioactivx
Singapore’s Bioactivx raises $3M for synthetic skin-substitute wound-care technology
Bioactivx, a Singapore deep-tech startup developing synthetic materials for wound care, has raised $3 million in a pre-Series A funding round co-led by the venture firm Cocoon Capital and Martin Krupp, managing director of the Swiss family office ContInvest, with other new and existing investors.
Singapore’s Bioactivx raises $1.43M in seed round led by Cocoon Capital
Bioactivx (BAX), a Singapore-based biomaterials startup, has closed its $1.43 million seed funding round led by Cocoon Capital, with participation from global strategic investors.
